Recombinant human complement factor H (Eleva GmbH)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameRecombinant human complement factor H (Eleva GmbH)
Drug Alias NameCompleva FHCPV-104
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionComplement factor H replacements
TargetsComplement factor H
Therapy Area/IndicationsC3 glomerulopathyGlomerulonephritis, Membranoproliferative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumSweden +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEleva GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEleva GmbH
Inactive CompaniesN/A
Active IndicationsC3 glomerulopathyGlomerulonephritis, Membranoproliferative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A